MGX (Metagenomi) Accounts Payable : $0.53 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Metagenomi Accounts Payable?

Metagenomi's Accounts Payable for the quarter that ended in Dec. 2024 was $0.53 Mil.

Metagenomi's quarterly Accounts Payable declined from Jun. 2024 ($3.45 Mil) to Sep. 2024 ($3.10 Mil) and declined from Sep. 2024 ($3.10 Mil) to Dec. 2024 ($0.53 Mil).

Metagenomi's annual Accounts Payable declined from Dec. 2022 ($2.01 Mil) to Dec. 2023 ($1.79 Mil) and declined from Dec. 2023 ($1.79 Mil) to Dec. 2024 ($0.53 Mil).

Metagenomi Accounts Payable Historical Data

The historical data trend for Metagenomi's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi Accounts Payable Chart

Metagenomi Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Accounts Payable

1.35

2.01

1.79

0.53

Metagenomi Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Payable	Get a 7-Day Free Trial							1.79	6.84	3.45	3.10	0.53

Metagenomi Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Metagenomi Accounts Payable Related Terms

Thank you for viewing the detailed overview of Metagenomi's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Metagenomi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

5959 Horton Street, Emeryville, CA, USA, 94608

Website

https://www.metagenomi.co

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).